uPharma-QC: Optofluidic-enabled smart QC platform for rapid end-to-end lot release of genetic medicines
The team will develop an all-in-one genetic medicine testing platform enabling full QC testing and lot release within as little as one day. Using digital microfluidics, advanced optics, and AI, the platform will perform multi-parametric characterization of therapeutics at nanoliter- to microliter-scales in a compact, single-use cartridges format.